Dr Mark Kris discusses the increasing precision of lung cancer therapies and the need for additional testing to find ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...
Opportunities in the Global Refractory Follicular Lymphoma Diagnostics Market include the growing need for MRD monitoring and ...
Kochi: Cancer diagnosis and related tests are available at very low rates in the pathology department of Govt Medical College Hospital (MCH), Ernakulam. The service includes immunohistochemistry ...
The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for ENHERTU® ...
Resource drilling at PTR Minerals’ Rosewood Titanium project in South Australia’s Gawler Craton has returned some of the ...
Daiichi Sankyo and AstraZeneca's Enhertu has been cleared for previously-untreated HER2-positive breast cancer in the US, becoming the first new first-line option in more than a decade. The FDA ...
ConcertAI, a leading oncology real-world evidence data and AI SaaS technology company, and Foundation Medicine, a global, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback